NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results
Initial Phase 1/2 data presented at the 63rd American Society of Hematology (ASH) Annual Meeting and ExpositionPhase 1/2 study of NEXI-002 as a monotherapy...
Source: globenewswire.com
Daniel Bednarik News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Daniel Bednarik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.